Molecular Architecture of Early Dissemination and Massive Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area.
Amino Acid Sequence
Amino Acid Substitution
Antibodies, Neutralizing
/ immunology
Base Sequence
Betacoronavirus
/ genetics
COVID-19
COVID-19 Testing
Clinical Laboratory Techniques
Coronavirus Infections
/ diagnosis
Coronavirus RNA-Dependent RNA Polymerase
Genome, Viral
Genotype
Humans
Machine Learning
Models, Molecular
Molecular Diagnostic Techniques
Pandemics
Phylogeny
Pneumonia, Viral
/ epidemiology
RNA-Dependent RNA Polymerase
/ chemistry
SARS-CoV-2
Sequence Analysis, Protein
Spike Glycoprotein, Coronavirus
/ chemistry
Texas
/ epidemiology
Viral Nonstructural Proteins
/ chemistry
COVID-19
COVID-19 disease
SARS-CoV-2
evolution
genome sequencing
molecular population genomics
Journal
mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231
Informations de publication
Date de publication:
30 10 2020
30 10 2020
Historique:
entrez:
31
10
2020
pubmed:
1
11
2020
medline:
20
11
2020
Statut:
epublish
Résumé
We sequenced the genomes of 5,085 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains causing two coronavirus disease 2019 (COVID-19) disease waves in metropolitan Houston, TX, an ethnically diverse region with 7 million residents. The genomes were from viruses recovered in the earliest recognized phase of the pandemic in Houston and from viruses recovered in an ongoing massive second wave of infections. The virus was originally introduced into Houston many times independently. Virtually all strains in the second wave have a Gly614 amino acid replacement in the spike protein, a polymorphism that has been linked to increased transmission and infectivity. Patients infected with the Gly614 variant strains had significantly higher virus loads in the nasopharynx on initial diagnosis. We found little evidence of a significant relationship between virus genotype and altered virulence, stressing the linkage between disease severity, underlying medical conditions, and host genetics. Some regions of the spike protein-the primary target of global vaccine efforts-are replete with amino acid replacements, perhaps indicating the action of selection. We exploited the genomic data to generate defined single amino acid replacements in the receptor binding domain of spike protein that, importantly, produced decreased recognition by the neutralizing monoclonal antibody CR3022. Our report represents the first analysis of the molecular architecture of SARS-CoV-2 in two infection waves in a major metropolitan region. The findings will help us to understand the origin, composition, and trajectory of future infection waves and the potential effect of the host immune response and therapeutic maneuvers on SARS-CoV-2 evolution.
Identifiants
pubmed: 33127862
pii: mBio.02707-20
doi: 10.1128/mBio.02707-20
pmc: PMC7642679
pii:
doi:
Substances chimiques
Antibodies, Neutralizing
0
Spike Glycoprotein, Coronavirus
0
Viral Nonstructural Proteins
0
spike protein, SARS-CoV-2
0
Coronavirus RNA-Dependent RNA Polymerase
EC 2.7.7.48
NSP12 protein, SARS-CoV-2
EC 2.7.7.48
RNA-Dependent RNA Polymerase
EC 2.7.7.48
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIAID NIH HHS
ID : R01 AI127521
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM120554
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM124141
Pays : United States
Commentaires et corrections
Type : UpdateOf
Informations de copyright
Copyright © 2020 Long et al.
Références
Lancet. 2020 Aug 15;396(10249):479-488
pubmed: 32702299
Nature. 2020 Aug;584(7819):115-119
pubmed: 32454513
Science. 2020 Sep 18;369(6510):1505-1509
pubmed: 32703908
Science. 2020 Jun 26;368(6498):1499-1504
pubmed: 32358203
PLoS One. 2010 Mar 10;5(3):e9490
pubmed: 20224823
J Biol Chem. 2020 May 15;295(20):6785-6797
pubmed: 32284326
Science. 2020 Aug 21;369(6506):1010-1014
pubmed: 32540901
Lancet. 2020 Feb 15;395(10223):514-523
pubmed: 31986261
Science. 2020 Mar 13;367(6483):1260-1263
pubmed: 32075877
J Immunol. 2020 Aug 15;205(4):915-922
pubmed: 32591393
N Engl J Med. 2020 Jun 11;382(24):2302-2315
pubmed: 32289214
Elife. 2020 Oct 28;9:
pubmed: 33112236
EBioMedicine. 2020 Dec;62:103112
pubmed: 33186810
Nature. 2021 Apr;592(7852):116-121
pubmed: 33106671
JAMA. 2020 Sep 15;324(11):1048-1057
pubmed: 32821939
N Engl J Med. 2020 Oct 15;383(16):1522-1534
pubmed: 32558485
Nature. 2020 Oct;586(7830):578-582
pubmed: 32731258
N Engl J Med. 2020 Oct 15;383(16):1544-1555
pubmed: 32722908
Antiviral Res. 2020 Jun;178:104793
pubmed: 32283108
Lancet. 2020 Feb 15;395(10223):470-473
pubmed: 31986257
mBio. 2020 Oct 30;11(6):
pubmed: 33127862
Cell. 2021 Jan 7;184(1):64-75.e11
pubmed: 33275900
Lancet. 2020 Aug 15;396(10249):467-478
pubmed: 32702298
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
Nat Commun. 2020 May 4;11(1):2251
pubmed: 32366817
Cell. 2016 Nov 3;167(4):1079-1087.e5
pubmed: 27814505
N Engl J Med. 2020 Nov 12;383(20):1920-1931
pubmed: 32663912
Cell. 2016 Nov 3;167(4):1088-1098.e6
pubmed: 27814506
Science. 2020 Aug 7;369(6504):650-655
pubmed: 32571838
Clin Infect Dis. 2021 Dec 6;73(11):e4166-e4174
pubmed: 32706859
Nature. 2020 Aug;584(7821):450-456
pubmed: 32698192
Cell. 2020 Apr 16;181(2):281-292.e6
pubmed: 32155444
Cell. 2020 Aug 6;182(3):744-753.e4
pubmed: 32553273
J Phys Chem B. 2020 Aug 20;124(33):7128-7137
pubmed: 32559081
Cell. 2020 Aug 20;182(4):812-827.e19
pubmed: 32697968
Science. 2020 Jul 17;369(6501):297-301
pubmed: 32471856
Science. 2020 Aug 7;369(6504):731-736
pubmed: 32540900
JAMA. 2020 Sep 8;324(10):998-1000
pubmed: 32789492
Euro Surveill. 2015 May 07;20(18):
pubmed: 25990233
N Engl J Med. 2020 Feb 20;382(8):760-762
pubmed: 31978944
Science. 2020 Sep 18;369(6510):1501-1505
pubmed: 32703906
J Virol. 2017 Jan 3;91(2):
pubmed: 27847361
N Engl J Med. 2020 Nov 5;383(19):1827-1837
pubmed: 32459919
Science. 2020 May 8;368(6491):630-633
pubmed: 32245784
Science. 2020 Aug 21;369(6506):1014-1018
pubmed: 32540904
Cell Host Microbe. 2020 Sep 9;28(3):445-454.e6
pubmed: 32585135
J Clin Invest. 2020 Dec 1;130(12):6728-6738
pubmed: 32910806
Nat Genet. 2019 Mar;51(3):548-559
pubmed: 30778225
mBio. 2018 Mar 6;9(2):
pubmed: 29511076
Glob Public Health. 2020 Nov;15(11):1589-1602
pubmed: 32894686
Proc Natl Acad Sci U S A. 2020 Mar 24;117(12):6771-6776
pubmed: 32054787
Science. 2020 Aug 21;369(6506):956-963
pubmed: 32540903
Science. 2020 Nov 27;370(6520):1110-1115
pubmed: 33037066
Science. 2020 Sep 25;369(6511):1586-1592
pubmed: 32694201
mBio. 2017 May 16;8(3):
pubmed: 28512093
Cell. 2020 Sep 3;182(5):1295-1310.e20
pubmed: 32841599
Science. 2020 Sep 4;369(6508):1255-1260
pubmed: 32703910
Cell Host Microbe. 2021 Jan 13;29(1):44-57.e9
pubmed: 33259788
Nature. 2020 Aug;584(7821):443-449
pubmed: 32668443
Science. 2020 May 15;368(6492):779-782
pubmed: 32277040
Nature. 2020 Oct;586(7830):583-588
pubmed: 32731257
Bioinformatics. 2009 May 1;25(9):1189-91
pubmed: 19151095
Eur J Hum Genet. 2020 Jun;28(6):715-718
pubmed: 32404885
Nat Microbiol. 2020 Apr;5(4):536-544
pubmed: 32123347
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
J Clin Microbiol. 2019 Jan 30;57(2):
pubmed: 30333126
Science. 2020 Aug 14;369(6505):812-817
pubmed: 32434946
Sci Rep. 2018 Jan 11;8(1):421
pubmed: 29323230
Cell. 2020 Oct 29;183(3):739-751.e8
pubmed: 32991842
N Engl J Med. 2020 Nov 5;383(19):1813-1826
pubmed: 32445440
Science. 2020 Aug 7;369(6504):643-650
pubmed: 32540902
Cell. 2020 Aug 20;182(4):828-842.e16
pubmed: 32645326
N Engl J Med. 2020 Jun 11;382(24):2327-2336
pubmed: 32275812
Am J Pathol. 2020 Nov;190(11):2290-2303
pubmed: 32795424
Science. 2021 Feb 5;371(6529):
pubmed: 33303686
Science. 2020 Oct 30;370(6516):571-575
pubmed: 32913002
Nature. 2020 Sep;585(7824):273-276
pubmed: 32516797
Cell. 2020 May 14;181(4):894-904.e9
pubmed: 32275855
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508